EDTA has gained use in ophthalmic solutions owing to its ability to bind metals. Therapeutically, EDTA has been used to remove calcified plaques that occur in the superficial cornea in band ...

Outlook Therapeutics' Lytenava has become the first ophthalmic formulation of VEGF inhibitor bevacizumab to be cleared for use by the NHS in England and Wales for treating wet age-related macular ...

Compr Ophthalmol Update. 2005;6(2):85-101. Antimicrobial medications for conjunctivitis are typically given as one drop (or one-half inch of ointment) four times daily for 5-7 days. Ointments have ...